Aduhelm: How to Fix Healthcare Payments by Paul Seegert

Share!

Insurance Thought Leadership - Nov 04, 2021

In July, I wrote an article that was critical of the newly authorized Alzheimer’s drug Aduhelm. Six months later, the market response is heartening and, in my opinion, a case study in what it will take to fix the way that we pay for healthcare in America. A review of the problem The FDA approved [...

Read Full Article